Cargando…

Factors Affecting the Intraluminal Therapy for Helicobacter pylori Infection

Helicobacter pylori (H. pylori) can be eradicated immediately while conducting an endoscopic examination. The eradication rate of intraluminal therapy for H. pylori infection (ILTHPI) is 53.7% (51/95) via local application of single-dose medicament containing amoxicillin, metronidazole, and clarithr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ho, Cheng-Yu, Liu, Ting-Wen, Lin, Yang-Sheng, Chen, Yen-Po, Chen, Ming-Jen, Wang, Horng-Yuan, Liou, Tai-Cherng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876938/ https://www.ncbi.nlm.nih.gov/pubmed/35208870 http://dx.doi.org/10.3390/microorganisms10020415

Ejemplares similares

The Impact of Gastric Juice pH on the Intraluminal Therapy for Helicobacter pylori Infection
por: Wang, Yu-Chio, et al.
Publicado: (2020)

Intraluminal Therapy for Helicobacter pylori Infection—Comparison of Medicament Containing Tetracycline, Metronidazole, and Bismuth versus Amoxicillin, Metronidazole, and Clarithromycin: A Randomized Controlled Study
por: Liu, Ting-Wen, et al.
Publicado: (2023)

Colonization of Helicobacter pylori in the gastric cardia: A comparison between the UFT300 and CLO tests
por: Liao, Po‐Hao, et al.
Publicado: (2018)

Toward population specific and personalized treatment of Helicobacter pylori infection
por: Liou, Jyh-Ming, et al.
Publicado: (2018)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy
por: Liou, Jyh-Ming, et al.
Publicado: (2022)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

Elevated Interleukin-32 Expression Is Associated with Helicobacter pylori-Related Gastritis
por: Peng, Liu-sheng, et al.
Publicado: (2014)

Retention Time Extended by Nanoparticles Improves the Eradication of Highly Antibiotic-Resistant Helicobacter pylori
por: Yao, Cheng-Jung, et al.
Publicado: (2022)

Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole
por: Tseng, Yen-Yu, et al.
Publicado: (2022)

The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors—A Nationwide Study
por: Liou, Jyh-Ming, et al.
Publicado: (2015)

The interplay between Helicobacter pylori and gastrointestinal microbiota
por: Chen, Chieh-Chang, et al.
Publicado: (2021)

Helicobacter pylori eradication improves glycemic control in type 2 diabetes patients with asymptomatic active Helicobacter pylori infection
por: Cheng, Kai‐Pi, et al.
Publicado: (2019)

First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2017)

Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
por: Tsai, Kun-Feng, et al.
Publicado: (2017)

Effects of Helicobacter pylori infection in gastrointestinal tract malignant diseases: From the oral cavity to rectum
por: Kuo, Yang-Che, et al.
Publicado: (2022)

Hyperglycemia combined Helicobacter pylori infection increases risk of synchronous colorectal adenoma and carotid artery plaque
por: Hu, Kuang-Chun, et al.
Publicado: (2017)

The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
por: Kuo, Chao-Hung, et al.
Publicado: (2012)

Helicobacter pylori and Systemic Disease
por: Kuo, Chao-Hung, et al.
Publicado: (2014)

Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trial
por: Chen, Chieh-Chang, et al.
Publicado: (2020)

Accuracy of faecal occult blood test and Helicobacter pylori stool antigen test for detection of upper gastrointestinal lesions
por: Lee, Yi-Chia, et al.
Publicado: (2013)

Impact of Helicobacter pylori Infection and Outcome of Anti-Helicobacter pylori Therapy in Patients with Reflux Laryngopharyngitis
por: Shen, Huili, et al.
Publicado: (2022)

Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections
por: Kuo, Chia-Jung, et al.
Publicado: (2019)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Helicobacter pylori Eradication Therapy Affect the Gut Microbiota and Ghrelin Levels
por: Martín-Núñez, Gracia Mª, et al.
Publicado: (2021)

The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria
por: Chiu, Yi-Chun, et al.
Publicado: (2013)

Mass Eradication of Helicobacter pylori to Prevent Gastric Cancer: Theoretical and Practical Considerations
por: Lee, Yi-Chia, et al.
Publicado: (2016)

Risk of head and neck cancer in patients with peptic ulcers and the effect of Helicobacter pylori treatment
por: Lu, Yen-Ting, et al.
Publicado: (2021)

Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaque
por: Yu, Lo-Yip, et al.
Publicado: (2019)

Dual therapy for Helicobacter pylori infection
por: Duan, Miao, et al.
Publicado: (2023)

Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma
por: Kuo, Sung-Hsin, et al.
Publicado: (2022)

A pro-inflammatory role for Th22 cells in Helicobacter pylori-associated gastritis
por: Zhuang, Yuan, et al.
Publicado: (2015)

Helicobacter pylori
por: Harris, A. W. (Adam W.), 1963-
Publicado: (1996)

Helicobacter Pylori
por: Aguilar Lasserre, Rubén
Publicado: (1998)

Helicobacter pylori Dormant States Are Affected by Vitamin C
por: Di Fermo, Paola, et al.
Publicado: (2023)

Eradication therapy may decrease the risk of immune thrombocytopenia after Helicobacter pylori infection: a retrospective cohort study in Taiwan
por: Koseki, Mitsuhiro, et al.
Publicado: (2023)

Helicobacter pylori–induced matrix metallopeptidase-10 promotes gastric bacterial colonization and gastritis
por: Lv, Yi-pin, et al.
Publicado: (2019)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

Helicobacter pylori infection and increased diabetes prevalence were the risks of colorectal adenoma for adults: A systematic review and meta-analysis (PRISMA-compliant article)
por: Ko, Hung-Ju, et al.
Publicado: (2021)

Glycosyltransferase Jhp0106 (PseE) contributes to flagellin maturation in Helicobacter pylori
por: Yang, Kai‐Yuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i9i9tcmgcnmen17pufnbv2886c